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Abstract Glucose-sensing (GS) behaviour in pancreatic β-
cells is dependent onATP-sensitive K+ channel (KATP) activity,
which is controlled by the relative levels of the KATP ligands
ATP and ADP, responsible for closing and opening KATP,
respectively. However, the mechanism by which β-cells trans-
fer energy status from mitochondria to KATP, and hence to
altered electrical excitability and insulin secretion, is presently
unclear. Recent work has demonstrated a critical role for AMP-
activated protein kinase (AMPK) in GS behaviour of cells.
Electrophysiological recordings, coupled with measurements
of gene and protein expression were made from rat insulinoma
cells to investigate whether AMPK activity regulates this en-
ergy transfer process. Using the whole-cell recording configu-
ration with sufficient intracellular ATP to keep KATP closed,
raised AMPK activity induced GS electrical behaviour. This
effect was prevented by the AMPK inhibitor, compound C and
required a phosphotransfer process. Indeed, high levels of
intracellular phosphocreatine or the presence of the adenylate
kinase (AK) inhibitor AP5A blocked this action of AMPK.
Using conditions that maximised AMPK-induced KATP open-
ing, there was a significant increase in AK1, AK2 and UCP2
mRNA expression. Thus we propose that KATP opening in
response to lowered glucose concentration requires AMPK
activity, perhaps in concert with increased AK and UCP2 to
enable mitochondrial-derived ADP signals to be transferred to
plasma membrane KATP by phosphotransfer cascades.
Keywords AMPK . KATP . Glucose .β-cell . Adenylate
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Introduction
ATP-sensitive K+ channels (KATP) act as metabolic sensors,
connecting changes in cellular energy status to cell excitabil-
ity. For pancreatic β-cells and some neurons, KATP are key
components of cellular glucose-sensing behaviour, whereby
changes in physiological glucose levels result in alterations in
membrane potential and cell excitability, leading to, for ex-
ample, insulin secretion (Ashcroft et al. 1984). Importantly, in
β-cells, KATP are partly open at normal glucose levels and
contribute to cell resting membrane potential. Consequently,
an increase or decrease of glucose results in closure, eliciting
depolarization, or further opening, causing hyperpolarization,
of KATP, respectively. Indeed, closure of KATP is a crucial step
in glucose-stimulated insulin secretion fromβ−cells (Ashcroft
and Rorsman 1990).
The precise mechanism(s) by which glucose regulates
KATP activity is unknown. There is an absolute requirement
for glucose to be taken up and metabolized in the β-cell prior
to closure of KATP, with the KATP ligands, ATP and ADP
principle determinants of channel activity (Kakei et al. 1986;
Ashcroft et al. 1988). In β-cells and some neurons, KATP
comprise a pore-forming Kir6.2 subunit, which binds ATP
and inhibits activity, and the regulatory sulphonylurea recep-
tor 1 (SUR1) subunit, which binds MgADP and stimulates
activity (Kakei et al. 1986). It is commonly believed that
glucose metabolism controls KATP by altering the intracellular
ATP levels or ATP/ADP ratio (Ghosh et al. 1991). However,
the fact that bulk cytoplasmic ATP concentration (low mM
range) is much higher than the half-maximal concentration of
ATP (~10–20 μM) required for channel closure (Lederer and
Nichols 1989) indicating KATP should be fully closed by
>1 mM ATP, raises questions about the validity of this hy-
pothesis. It has been argued that changes in nucleotide levels
or other mediators in a channel ‘micro-environment’ could
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alter KATP activity and/or ATP sensitivity (Kennedy et al.
1999; Ainscow et al. 2002). In this micro-environment, ATP
levels close to the channel might be regulated by ATPases
(Nichols and Lederer 1990) or production of lipids that mod-
ulate KATPATP sensitivity (Shyng and Nichols 1998; Larsson
et al. 1996; Buschard et al. 2006). But, local depletion of ATP
is unlikely to explain increased KATP activity by low glucose
concentrations in intact β-cells (Kennedy et al. 1999; Tarasov
et al. 2006), and there is no clear evidence to support direct
lipid modulation of KATP channel sensitivity (Tarasov et al.
2006), particularly during fluctuations in glucose levels. Al-
ternatively, Mg-ADP stimulation of SUR1 can increase KATP
activity even in the constant presence of mM levels of ATP,
and this may therefore explain glucose-dependent control of
channel activity (Tarasov et al. 2006). This presupposes that
metabolism, most likely from mitochondria (Kennedy et al.
1999), results in changes in Mg-nucleotides at or very close to
the channel to influence channel activity (Kennedy et al.
1999). This altered cellular energy status must be signalled
from mitochondria to plasma membrane KATP channels. In-
tracellular phosphotransfer networks may provide this func-
tion (Schulze et al. 2007; Stanojevic et al. 2008).
Phosphotransfer reactions catalyzed by adenylate
kinase/creatine kinase, pyruvate kinase and glycolytic en-
zymes have been implicated in KATP regulation (Elvir-
Mairena et al. 1996; Weiss and Lamp 1987; Olson et al.
1996; Dzeja and Terzic 1998) and phosphotransfer networks
are important in transduction of metabolic signals to KATP in
cardiac cells (Weiss and Lamp 1987; Crawford et al. 2001;
Abraham et al. 2002).
Another important energy sensor is AMP-activated protein
kinase (AMPK), which acts to maintain cellular energy ho-
meostasis by regulation of multiple metabolic pathways
(Hardie et al. 2012). Increased AMPK activity reduces
glucose-stimulated insulin secretion (Da Silva Xavier et al.
2003; Tsuboi et al. 2003), whereas reduced AMPK activity by
over-expression of a dominant negative AMPK increased
insulin secretion at low glucose concentrations (Da Silva
Xavier et al. 2003), although not all studies have replicated
these findings (Dufer et al. 2010). Genetic ablation of AMPK
catalytic subunits from β-cells also indicate that AMPK plays
an important role in glucose-stimulated insulin secretion (Sun
et al. 2010). For instance, removal of the AMPKα2 subunit
from β-cells (Beall et al. 2010; Sun et al. 2010) and certain
hypothalamic neurons (Beall et al. 2012; Claret et al. 2007)
prevents cell hyperpolarization (by activation of KATP) fol-
lowing reduction of extracellular glucose concentration, indi-
cating a central role for AMPK in hypoglycaemic sensing.
Thus AMPK plays an important role in transmission of met-
abolic signals between the sites of glucose metabolism and
KATP regulation. However, at present no molecular mecha-
nism explains how AMPK influences this process. In heart,
metabolic status is coupled to KATP by AK (Carrasco et al.
2001), which is closely associated with KATP (Elvir-Mairena
et al. 1996), as is CK (Crawford et al. 2001). Furthermore,
skeletal muscle CK is inhibited by AMPK (Ponticos et al.
1998) and it has previously been suggested that AK, CK and
AMPK act in concert to maintain cellular energy homeostasis
(Neumann et al. 2003). In the current study we sought to
examine the hypothesis that glucose-dependent KATP gating
in the pancreaticβ-cell is contingent on AK and CK-catalysed
phosphotransfer networks, and that these in turn may be
regulated by AMPK. Using the CRI-G1 rat insulinoma cell
line, previously shown to exhibit KATP-dependent electrical
sensitivity to reduced glucose (26), we report that inhibition of
AK occludes glucose-sensing, which is mimicked by both
phosphocreatine supplementation and pharmacological inhi-
bition of AMPK. Furthermore, we report that AMPK activa-
tion increases AK isoform expression and mitochondrial
uncoupling protein 2 (UCP2) expression. Together, these data
suggest that AK, CK and AMPK coordinate to couple cellular
energy status to KATP channel regulation.
Methods
Cell culture and islet isolation
The rat insulinoma cell line, CRI-G1 (Carrington et al. 1986)
was grown in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum (Sigma), 1 mM L-
glutamine and 1% penicillin-streptomycin at 37 °C in a hu-
midified atmosphere of 95% air and 5% CO2. Cells were
passaged every 3–4 days, and used 1–4 days after plating.
Electrophysiological recording and analysis
CRI-G1 insulinoma cells were superfused at room tempera-
ture (22–25 °C) with normal saline, comprising (in mM): 135
NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 HEPES, 10 glucose
(pH 7.4). Membrane potentials were recorded using the
whole-cell current clamp configuration, and macroscopic
membrane currents monitored by whole-cell voltage clamp,
using an Axopatch 200B amplifier. Cells were maintained
under current-clamp to monitor resting membrane potential,
with short excursions into voltage clamp to obtain macroscop-
ic current–voltage relations. In voltage-clamp recordings, the
membrane potential was held at −70 mVand 20 mV steps of
200ms duration, with 20ms between pulses, applied (range of
voltages: –160 to −40 mV). Whole cell voltage-clamp data
were analysed using pCLAMP 8.2 (Molecular Devices).
Current-clamp data were recorded and stored either onto
digital audiotapes and replayed for analysis and illustration
on a Gould TA240 chart recorder, or directly on PC for later
analysis. Recording electrodes were pulled from borosilicate
glass and had resistances of 5–10MΩwhen filled with pipette
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solution, which comprised (in mM) 140 KCl, 5 MgCl2, 3.8
CaCl2, 10 EGTA, 10 HEPES, pH 7.2 (free [Ca
2+] of 100 nM),
in the absence or presence of ATP (5mM). In somewhole-cell
recordings, additional metabolites or other nucleotides were
added directly to this pipette solution. Series resistances were
compensated using an Axopatch 200B amplifier in current
(Ifast) and voltage-clamp modes and cells with a series resis-
tance of >15 MΩ were rejected. Following a minimum of
10 min of stable recording, drugs were applied by bath
superfusion and/or extracellular glucose concentration was
altered.
Western blotting
CRI-G1 cells, grown in six-well plates, were exposed to
normal saline for 30 mins, before treatment with AICAR, A-
769662 or saline. Protein isolation, content, immunoblotting
and analysis procedures were as previously described
(Mirshamsi et al. 2004). p-AMPK (Thr-172) and p-ACC
(Ser-79) antibodies were obtained from Cell Signalling and
used at 1:1000. Monoclonal mouse anti β-actin antibody
(used at 1:5000) was from MP Biochemicals. Protein bands
on gels were quantified by densitometry, where total density
was determined with respect to constant area, background
subtracted and average relative band density calculated.
Adenylate kinase activity
Adenylate kinase forward reaction activity was determined
by measuring the oxidation of NADH by coupling the AK
reaction with pyruvate kinase and lactate dehydrogenase as
previously described (Huss and Glaser 1983). Briefly, cell
supernatants were added to a reaction mixture consisting of
(in mM): AMP (1), ATP (1), KCl (100), lactate dehydroge-
nase (3 U/ml), MgCl2 (10), NADH (0.1), PEP (1), pyruvate
kinase (3 U/ml) and Tris (100). Absorbance was measured at
340 nm.
Gene expression
Total RNAwas isolated using TRI Reagent (Sigma Aldrich)
and then reversed transcribed using Superscript II (Life
Technologies, Paisley, UK) and random primers. AK1,
AK2, AK5 and UCP2 gene expression was assayed relative
to cyclophilin A RNA by real-time PCR using premixed
primer-probe sets specific for mouse (Applied Biosystems,
Foster City, Calif., USA).
Chemicals
AMP, ATP, 5-adenylylimidodiphosphate (AMP-PNP),
diadenosine pentaphosphate (AP5A), creatine phosphate,
diazoxide, lactate dehydrogenase, phosphoenolpyruvate
(PEP), pyruvate kinase, β-nicotinamide adenine dinucleo-
tide (NADH), and tolbutamide were from Sigma-Aldrich.
Compound C was from Calbiochem, 5-aminoimidazole-4-
carboxamide-1-b-D-ribofuranoside (AICAR) was from To-
ronto Research Chemicals (Toronto, Canada) and A-769662
was from Ascent Scientific, UK.
Statistical analysis
Data are presented as means ± S.E.M. All statistical analyses
were performed using GraphPad Prism (Prism 5) software.
ANOVA, one sample t-test, Student’s paired or unpaired t-
tests were performed as appropriate. P values≤0.05 were
considered statistically significant.
Results
Increased AMPK activity induces glucose-sensing
behaviour in CRI-G1 cells in whole-cell recordings
To explore the possible mechanisms by which AMPK enables
glucose metabolism to couple to KATP in β-cells, we exam-
ined whether the nucleotide sensitivity of KATP was altered
under conditions of increased AMPK activity using whole-
cell recordings. This recording configuration provides a num-
ber of advantages over perforated patch recordings. It allows
the intracellular ATP concentration to remain at a fixed con-
centration (5 mM) and allows rapid dialysis of drugs, at
known concentrations, where non-cell permeable agents
would be ineffective if given by bath application. It also
permits direct and quantitative measurement of KATP channel
currents. In control whole cell recordings, with 5 mM ATP in
the pipette solution and 10 mM glucose in the extracellular
saline, the mean resting membrane potential of CRI-G1 cells
was – 43.4±1.1 mV (n=40) and remained stable for
prolonged recording periods (≥ 1 h), although many cells
stopped firing. Acute exposure to aglycaemia (for 15–
20 min) or the application of the AMPK activators, 1 mM
AICAR or 50 μM A-769662 (for 15 min) had no significant
effect on CRI-G1 restingmembrane potential (Fig. 1a–c). This
was the predicted outcome using whole cell recording because
high levels of internal ATP would be expected to keep KATP
channels closed. However, prolonged (≥ 40 min; Fig. 1a)
and/or multiple exposure of CRI-G1 cells to aglycaemia
resulted in the induction of GS behaviour, with rapid, revers-
ible and reproducible hyperpolarization-repolarization cycles
in response to removal and subsequent replacement of 10 mM
extracellular glucose (Fig. 1a). This behaviour was also elic-
ited by exposure of CRI-G1 cells, under the same whole cell
recording conditions (5 mMATP in the electrode solution), to
1 mM AICAR (≥ 40 min) or 50 μM A-769662 for approxi-
mately 30 min (Fig. 1b, c). Once initiated, this electrical
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response to glucose removal and replacement was consistent,
reproducible and observed in every cell, which had undergone
one of the above treatments (n=40).
To confirm that these treatments increased AMPK activ-
ity in these cells, CRI-G1 cells were treated with AICAR
(1 mM) or A-769662 (50 μM) and AMPK phosphorylation
assessed by immunoblotting. These pharmacological activa-
tors of AMPK induced a sustained increase (Fig. 1d, e) in
the levels of phosphorylated AMPK (p-AMPK) and its
substrate ACC (p-ACC), indicative of raised AMPK activity
(Sim and Hardie 1988).
In subsequent studies, we used A-769662 to induce
glucose-sensing behaviour in the whole-cell configuration
because this agent required a short exposure time and is a
relatively selective activator of AMPK (Cool et al. 2006;
Goransson et al. 2007). As glucose-sensing behaviour oc-
curred under whole-cell recording conditions with high
levels of ATP in the electrode solution, the effects of glucose
removal and replacement were also examined under
voltage-clamp, enabling direct and quantitative determina-
tion of KATP current. In control cells, in the absence of A-
769662, acute removal and replacement of glucose had no
significant effect on the mean membrane potential (see
Fig. 1a) or the current amplitude (Fig. 2a), although subse-
quent application of diazoxide (250 μM) hyperpolarized the
CRI-G1 cells (data not shown) and increased the current
amplitude resulting in an increased mean conductance den-
sity, actions that were completely reversed by the addition of
200 μM tolbutamide (Fig. 2a). Similarly, CRI-G1 cells
acutely (5–10 min) exposed to A-769662 (50 μM) in the
presence of 10 mM glucose exhibited no change in current
amplitude or mean conductance density (data not shown), in
comparison to control (10 mM glucose), in agreement with
the lack of effect of the AMPK activator per se on the
resting membrane potential of these cells (Fig. 1b). In con-
trast, following exposure to A-769662 for approximately
30 min, removal of extracellular glucose rapidly increased
the current amplitude, indicating a substantial increase in the
mean slope conductance density (Fig. 2b). The increase in
current was rapidly reversed by re-introduction of 10 mM
glucose and recovered on a second aglycaemic episode
(Fig. 2b). The aglycaemia-induced conductance could be
further increased by the presence of diazoxide, and the
currents induced by these stimuli were completely blocked
by tolbutamide, which returned the mean conductance den-
sity to control values (Fig. 2b).
Current-clamp recordings showed that the presence in the
pipette solution of the AMPK inhibitor, compound C
(10 μM) (Zhou et al. 2001), had no significant effect on
the membrane potential of CRI-G1 cells in the whole-cell
recording configuration, in comparison to untreated con-
trols. However, compound C prevented A-769662 from
inducing sensitivity to aglycaemic challenge, with no
significant change in CRI-G1 mean resting membrane po-
tential elicited by the removal of glucose (Fig. 3a). Analysis
of the voltage-clamp data (Fig. 3b) showed that aglycaemia
did cause a small, but not significant, increase in the mean
conductance density in the presence of compound C, per-
haps suggesting incomplete inhibition of AMPK activation
by A-769662. KATP was not directly inhibited by compound
C as diazoxide hyperpolarized the membrane potential and
increased the conductance density of treated cells by similar
magnitude to controls, actions reversed by the addition of
tolbutamide (Fig. 3a, b). Taken together, the induction of
glucose-sensing under whole-cell recording conditions in
CRI-G1 cells by aglycemia, AICAR or A-769662 and the
inhibition of A-769662-induced glucose-sensing by com-
pound C strongly suggest that increased AMPK activity
underlies this effect.
Altered KATP channel maximum conductance
is not responsible for A-769662 mediated induction
of glucose-sensing
We considered a number of possible explanations for the
initiation of glucose-sensing behaviour by increased AMPK
activity. Previously we reported that mouse AMPKα2 null
islets exhibited reduced mRNA levels of the KATP subunit,
SUR1 (Beall et al. 2010). Thus one possible explanation is
that augmented AMPK activity brings about an increased
number of functional KATP channels in the plasma mem-
brane (Lim et al. 2009), resulting in higher sensitivity to
local changes in nucleotide levels when extracellular glu-
cose is removed and re-applied. Therefore we examined
Fig. 1 Induction of glucose-sensing in CRI-G1 cells by AMPK-activating
procedures in whole-cell recordings. a Representative recording showing
the electrical response of CRI-G1 cells to repetitive episodes of aglycaemia.
Note the initial resistance of cell to hyperpolarisation in the presence of
0 glucose, and subsequent induction of reversible hyperpolarising re-
sponses to removal of glucose. Bar graph showsmean values of membrane
potential in 10 mM glucose, the first response to 0 glucose and return to
10 mM glucose, and subsequent response to 0 glucose (n=7). b, c Repre-
sentative recordings showing that exposure of CRI-G1 cells to AICAR
(1 mM) or A-769662 (50 μM) has no acute effect on resting membrane
potential or firing activity, but following 30–40 min exposure results in
induction of glucose-sensing behaviour, with reversible cell
hyperpolarisation responses to removal of glucose. Bar graphs (n=9) show
mean values of membrane potential in 10 mM glucose and in the presence
of AICAR (b) and A-769662 (c) and responses to 0 mM glucose after 30–
40 min exposure to the AMPK activators. Note in (c) presence of tolbuta-
mide (200 μM) in 0 mM glucose reverses effects of 0 mM glucose and
depolarises cells. # denotes significant (p<0.05) reduction in membrane
potential versus 10 mM glucose control. d Representative immunoblots
showing the effect of AICAR (1mM) on p-AMPK and p-ACC levels, with
actin as loading control. Bar graphs show relative mean levels of p-AMPK
and p-ACC as a function of time (n=10) in the presence of AICAR. e
Representative immunoblot showing the effect of A-769662 (50 μM) on p-
AMPK level, with actin as loading control. Bar graph shows relative mean
levels of p-AMPKas a function of time (n=3) in the presence ofA-769662.
Values are means ± SEM. *p<0.05, **p<0.01, ***p<0.001
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CRI-G1 cells in control (10 mM glucose) conditions or in the
presence of A-769662, under voltage-clamp with no ATP in
the pipette solution, consequently inducing maximal opening
of KATP and showed that A-769662 treatment did not alter the
mean conductance density following maximal run-up of KATP
conductance (Fig. 3c).
A fall in intracellular malonyl CoA is not required
for A-769662 mediated induction of glucose-sensing
We next decided to test whether an AMPK-mediated decrease
in malonyl CoA levels contributed, through changes in fuel
partitioning and altered local levels of long-chain acyl CoA
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Fig. 2 AMPK activation enables aglycaemia to activate KATP in whole
cell recording configuration. a Representative families of currents
recorded under voltage-clamp from a CRI-G1 cell exposed to 10 mM
glucose, 0 mM glucose, 0 mM glucose + diazoxide (250 μM; DZX)
and 0 mM glucose + tolbutamide (200 μM). Bar graph denotes mean
conductance density (n=3–6) obtained under these recording condi-
tions. b Representative families of currents recorded under voltage
clamp from a cell pre-treated with A-769662 (50 μM) from 40 min
and exposed to, over 15–20 min intervals to 10 mM and 0 mM glucose,
twice, then 0 mM glucose + DZX (250 μM), then 0 mM glucose +
tolbutamide (200 μM). Current–voltage relationship showing mean
current amplitudes (n=6) from voltage-clamped currents in the pres-
ence of 10 mM and 0 mM glucose. Bar graph denotes mean conduc-
tance density (n=6) obtained for 10 mM and 0 mM glucose and 0 mM
glucose in the presence of tolbutamide. Values are means ± SEM. *p<
0.05, ***p<0.001
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molecules, to glucose-dependent alteration of KATP. Whole
cell recordings were performed with 40 μMmalonyl CoA and
5 mM ATP present in the pipette solution. Current-clamp
recordings show that malonyl CoA had no effect on the mean
resting membrane potential of CRI-G1 cells compared to
control (5 mM ATP) conditions and had no influence on the
ability of A-769662 to trigger glucose-sensing (Fig. 3d). Thus,
following treatment of cells with A-769662, an aglycaemic
challenge increased KATP conductance and hyperpolarized
cells to potentials similar to that observed for control cells in
the absence of intracellular malonyl CoA (compare Fig. 3d
with Fig. 1c).
Induction of glucose-sensing behaviour by A-769662
requires a phosphotransfer reaction
Next we determined whether the A-769662 mediated induc-
tion of glucose-sensing involves a phosphorylation or
phosphotransfer process. Therefore ATP was replaced
wi th the non-hydro lysab le ATP ana logue 5 ′ -
adenylylimidodiphosphate (AMP-PNP; 5 mM) in the
pipette solution. The mean CRI-G1 cell resting mem-
brane potential and conductance density were not sig-
nificantly different compared to control (5 mM ATP)
recordings in the absence or presence of A-769662
(Fig. 3e). The presence of AMP-PNP prevented the
appearance of glucose-sensing behaviour in CRI-G1
cells, with no hyperpolarization of membrane potential
or increased conductance densi ty apparent on
aglycaemic challenge. Indeed, removal of glucose in-
duced a significant depolarization of the resting mem-
brane potential, although this was not accompanied by a
significant change in conductance (Fig. 3e, f). In the
presence of high intracellular levels of AMP-PNP,
diazoxide did not hyperpolarize (data not shown) or
increase the conductance density of these cells
(Fig. 3f), indicative of an inability to open KATP. This
outcome was as expected for diazoxide in the presence
of a non-hydrolysable ATP analogue (Kozlowski et al.
1989). Thus, the ability of A-769662, and subsequent
increase in AMPK activity, to elicit glucose-sensing in
CRI-G1 cells in the whole cell recording configuration
appears dependent on some form of phosphotransfer
reaction.
Adenylate kinase phosphotransfer mediates A-769662
induction of glucose-sensing
To explore whether the phosphotransfer cascade system
contributes to glucose-sensing in CRI-G1 cells induced by
A-769662, we first examined the effect of phosphocreatine
(PCr), which buffers and maintains intracellular ADP to low
levels (Wallimann et al. 1992). Whole-cell recordings were
made from CRI-G1 cells, with 14 mM PCr and 5 mM ATP
in the pipette solution. The presence of PCr did not signif-
icantly alter the resting membrane potential or conductance
density at 10 mM glucose in the absence or presence of A-
769662 (Fig. 4a and data not shown). Cells treated with A-
769662 and subsequently challenged by aglycaemia did not
exhibit any hyperpolarization or increase in cell conduc-
tance density, although as observed for AMP-PNP, a signif-
icant depolarization of the resting membrane potential
occurred (Fig. 4a). CRI-G1 KATP was functional under these
conditions, as diazoxide (250 μM) caused hyperpolarization
and increased conductance, effects reversed by 200 μM
tolbutamide (Fig. 4a). This outcome indicates that signifi-
cant levels of ADP are required for the induction of glucose-
sensing in CRI-G1 cells under this recording configuration.
We considered adenylate kinase (AK) the most likely
candidate to cause an increase in ADP in the vicinity of
KATP, as previous studies have shown that the AK1 isoform
associates with Kir6.2 in immunoprecipitates from mouse
cardiac (Carrasco et al. 2001) and mouse brain and
insulinoma cells (Stanojevic et al. 2008). To explore the
notion that AK activity underlies the A-769662 mediated
induction of glucose-sensing, we added the AK inhibitor
(Vanderlijn et al. 1979) diadenosine pentaphosphate (AP5A)
to the pipette solution. In whole-cell recordings, with 50 μM
AP5A and 5 mM ATP present in the pipette solution, the
mean resting membrane potential and conductance density
were unaltered, in 10 mM glucose in the absence or pres-
ence of A-769662, compared to control recordings (Fig. 4b
and data not shown). An aglycaemic challenge, following
A-769662 application, did not result in cell hyperpolariza-
tion or an increase in conductance density, although the
ability of diazoxide to hyperpolarize these cells and increase
conductance was unimpeded (Fig. 4b). Thus inhibition of
AK with presumably a concomitant reduction of ADP levels
close to KATP is sufficient to prevent the initiation of A-
769662 stimulated glucose-sensing. These data indicate that
raised AMPK activity in this recording configuration causes
altered AK activity and the induction of the phosphotransfer
reaction in the direction of ADP production, enabling
changes in glucose metabolism to be sensed by KATP
channels.
We next examined the levels of mRNA for AK isoforms,
reported to be present in β-cells, namely AK1, AK2 and
AK5. We found that CRI-G1 cells contained transcripts for
AK1, AK2 and AK5, with AK5 mRNA being expressed at a
much lower level (Fig. 4c). Importantly, mRNA expression
of AK1 and AK2, the cytosolic and mitochondrial isoforms,
respectively, was significantly increased by A-769662 treat-
ment. AK5 expression also increased but this did not reach
significance (Fig. 4d). We also measured cellular AK activ-
ity in the forward reaction (ADP generation from AMP and
ATP) using the indirect fluorometric assay. AK activity was
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modestly increased in the presence of A-769662, although
this also did not reach significance (data not shown). We
next asked the question whether UCP2 mRNA expression
was altered by acute AMPK activation, which may result in
enhanced mitochondrial ADP generation. Treatment of
CRI-G1 cells with A-769662 caused a significant increase
of UCP2 mRNA expression (Fig. 4e) confirming previous
observations that AMPK controls UCP2 expression in beta
cells (Beall et al. 2010; Wang et al. 2010).
Discussion
CRI-G1 cells were used as surrogate pancreatic β-cells to
investigate the influence of AMPK on glucose-sensing. We
utilised the whole cell configuration, in order to accurately
assess KATP activity and observed AICAR, A-769662 and
aglycaemia-dependent induction of glucose-sensing behav-
iour in cells where intracellular ATP levels were clamped at
a concentration that normally maintains all KATP in the
closed conformation. The induction of glucose-sensing in
the whole-cell configuration was prevented by the presence
of compound C, indicating that this behaviour requires
AMPK activity. However, this was not dependent on down-
stream regulation of ACC, as clamping intracellular malonyl
CoA levels did not alter the induction of glucose-sensing by
AMPK activators. These data combined with recent studies
investigating reduced AMPK on β-cell function (Beall et al.
2010; Sun et al. 2010) strongly implicate a key role for
AMPK in mediating glucose-sensing behaviour in β-cells.
The molecular target by which changes in AMPK activity
may elicit this outcome is presently unclear (Beall et al.
2010). However, a key role for phosphotransfer cascades,
which catalyse nucleotide exchange, has been proposed for
the transduction of energy signals into alterations in electri-
cal events in cardiac (Elvir-Mairena et al. 1996; Crawford et
al. 2001) and pancreatic β-cells (Schulze et al. 2007;
Krippeit-Drews et al. 2003; Stanojevic et al. 2008), through
the modulation of KATP. In these models it is proposed that
CK directs phosphotransfer transitions from the ADP to
ATP liganded state, whereas AK promotes the transition
from the ATP to the ADP liganded state, the latter being
regulated by the availability of AMP and ADP (Stanojevic
et al. 2008). In this way, small changes in metabolic status
can be amplified without major changes in bulk nucleotide
levels. Accordingly we found that intracellular AMP-PNP
prevented the induction of glucose-sensing behaviour by
AMPK activation and abolished the opening of KATP by
diazoxide. This confirmed that phosphotransfer reactions
and/or ATP hydrolysis are required for normal glucose-
sensing and KATP activity. Several reports have suggested
that CK exerts an inhibitory influence on KATP activity in β-
cells by supplying phosphocreatine, thus buffering sub plas-
ma membrane ATP levels (Krippeit-Drews et al. 2003).
Intracellular application of phosphocreatine prevented
glucose-sensing in CRI-G1 cells, demonstrating the inhibi-
tory role of this system on aglycaemia-induced KATP acti-
vation and cell hyperpolarization. On the other hand,
adenylate kinase has been suggested to promote KATP open-
ing (Schulze et al. 2007; Stanojevic et al. 2008; Carrasco et
al. 2001) by supplying ADP in the vicinity of the channel.
Importantly, we found that intracellular application of
AP5A, an inhibitor of AK, prevented aglycaemia-induced
membrane potential regulation, suggesting that AMPK-
mediated glucose-sensing requires AK activity.
Consequently we asked how AMPK could interact with
this phosphotransfer system to induce glucose-sensing?
Based on our previous data, we hypothesised that the influ-
ence of AMPK on glucose-sensing was chronic, by
maintaining the structural and/or functional integrity of the
components of the signalling complex required for glucose-
sensing. Accordingly, we determined whether AMPK acti-
vation affected AK isoform mRNA expression or cellular
AK activity. We found significantly increased mRNA ex-
pression for AK1 and AK2 with a non-significant trend
toward increased AK5 mRNA and overall AK activity.
However the expression of the AK5 isoform was signifi-
cantly lower than either AK1 or AK2. In pancreatic β-cells,
AK1 and AK5 (Stanojevic et al. 2008) are thought to be
mainly cytosolic with AK2 located in the mitochondrial
intermembrane space (Van Rompay et al. 2000). Further-
more, recent data have suggested a role for AMPK in
Fig. 3 AMPK activity and ATP hydrolysis are required for initiation
of glucose-sensing in CRI-G1 cells. a Representative recording from a
CRI-G1 cell in the whole cell configuration that was pre-treated with
A-769662 (50 μM) with compound C (40 μM) present in the pipette
solution and challenged with aglycaemia, then DZX (250 μM) and
tolbutamide (200 μM). Bar graph shows mean values of membrane
potential (n=6) for these treaments. # denotes significant (p<0.05)
reduction in membrane potential versus 10 mM and 0 mM glucose. b
Mean conductance density (n=6) for 10 mM and 0 mM glucose, 0 mM
glucose + DZX and 0 mM glucose + tolbutamide. c Treatment of CRI-
G1 cells with A-769662 (50 μM) has no significant effect on the
maximum conductance density (n=5–6) attained on removal of intra-
cellular ATP. Slopes measured from voltage-clamped currents shortly
after attaining whole-cell recording (i.e. before significant washout of
ATP) and 20 min later (after maximal washout of cellular ATP,
allowing KATP current to run-up). d The presence of malonyl CoA
(40 μM) in the pipette solution did not prevent A-769662-treated cells
from responding to aglycaemic challenge with membrane hyperpolar-
ization. Bar graph shows mean membrane potential (n=5) following
consecutive exposure to 10 mM glucose, 0 mM glucose, 10 mM
glucose and 0mM glucose + tolbutamide (200 μM). e AMP-PNP
(5 mM) in the pipette solution prevented A-769662 pre-treatment
induction of glucose-sensing and blocked diazoxide stimulation of
KATP. Bar graph shows mean values of membrane potential (n=6–7)
for 10 mM glucose, 10 mM glucose after A-769662 and for 0 mM
glucose. fMean conductance density (n=6–7) for 10 mM glucose after
A-769662 treatment, 0 mM glucose and 0 mM glucose + DZX. Values
are means ± SEM. **p<0.01, ***p<0.001
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Fig. 4 Phosphotransfer reactions are required for AMPK-mediated
glucose-sensing behaviour in CRI-G1 cells. a The presence of PCr
(14 mM) and ATP (5 mM) in the pipette solution blocked A-769662
(50 μM) induction of glucose-sensing behaviour with no effect on
diazoxide sensitivity. Bar graphs show mean values of membrane
potential (n=4) for 10 mM glucose, 10 mM glucose after A-769662,
0 mM glucose, 0 mM glucose + DZX (250 μM) and 0 mM glucose +
tolbutamide (200 μM), and of conductance density (n=4) following A-
769662 for 10 mM glucose, 0 mM glucose, 0 mM glucose + DZX
(250 μM) and 0 mM glucose + tolbutamide (200 μM). b The presence
of AP5A (50 μM) and ATP (5 mM) in the pipette solution blocked A-
769662 (50 μM) induction of glucose-sensing behaviour with no effect
on diazoxide sensitivity. Bar graphs show mean values of membrane
potential (n=6) and conductance density (n=6) for 10 mM glucose,
0 mM glucose, 0 mM glucose + DZX (250 μM) and 0 mM glucose +
tolbutamide (200 μM). ## denotes significant (p<0.01) reduction in
membrane potential versus 10 mM and 0 mM glucose. c Adenylate
kinase expression (as ratio of cyclophilin) measured in CRI-G1 cells in
the presence of 10 mM glucose (n=12). d Adenylate kinase isoform
expression (n=12) following treatment with A-769662 (50 μM; A-7)
versus 10 mM glucose saline controls (C). e Treatment of CRI-G1 cells
with A-769662 (50 μM) and exposure to 0 mM glucose increases
UCP2 mRNA expression (n=6). Values are means ± SEM. *p<0.05,
**p<0.01, ***p<0.001
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regulating UCP2 expression in pancreatic β-cells (Wang et
al. 2010; Beall et al. 2010). Increased UCP2 expression leads
to decreased ATP production (Hong et al. 2001), potentially
increasing or maintaining cellular ADP levels and reducing
insulin secretion (Hong et al. 2001; Zhang et al. 2001). Our
data showing that aglycaemia and A-769662 treatment of
CRI-G1 cells increased UCP2 expression is in line with this
notion. Consequently, how might AMPK, UCP2, AK, CK
and KATP coordinate to regulate glucose-sensing behaviour?
Importantly, AK catalyses the transfer of mitochondrial gen-
erated signals towards KATP (Carrasco et al. 2001). Therefore,
our hypothesis (see Fig. 5) is that under low glucose condi-
tions AMPK activity is increased, which in turn increases
UCP2 and AK isoforms expression/activity. Subsequently,
there is a decrease in endogenous diadenosine polyphosphate
(APxP) production, which relieves the inhibition of AK,
allowing the mitochondrial ADP signal to be relayed toward
KATP channels. Simultaneously, AMPK-mediated inhibition
of CK, prevents PCr-mediated ATP re-generation close to the
KATP channel, allowing the ADP:ATP ratio to increase, facil-
itating channel opening. This hypothesis is supported by the
observations that low glucose-induced KATP activity is ablated
in pancreatic β-cells (Beall et al. 2010) and hypothalamic
neurons lacking α2AMPK (Beall et al. 2012; Claret et al.
2007) and this is associated with diminished UCP2 levels.
Furthermore, glucose-dependent suppression of AK activity is
required for β-cell KATP closure and glucose-stimulated insu-
lin secretion (Olson et al. 1996). It has also been reported that
creatine supplementation amplifies glucose-stimulated insulin
secretion in vivo (Rooney et al. 2002), consistent with the
hypothesis that CK-mediated phosphocreatine inhibits KATP
activity (Krippeit-Drews et al. 2003). Indeed, in heart at least,
CK is physically associated with KATP (Crawford et al. 2001)
as is AMPK (Yoshida et al. 2012), and AMPK has been
reported to inhibit CK (Ponticos et al. 1998). In heart and β-
cells, AK is also closely associated with KATP (Zhang et al.
2001; Elvir-Mairena et al. 1996) leading us to propose that
AK, CK, AMPK and KATP exist as a complex that regulates
KATP activity depending on metabolic status. It should be
noted however, that we have been unable to demonstrate a
role for AMPK in directly regulating KATP, as has been pre-
viously reported (Dufer et al. 2010; Chang et al. 2009; Wang
et al. 2005). Taken together, these data lead us to suggest that
although low glucose-induced KATP opening requires AMPK
activity, raised AMPK activity per se does not drive KATP
activation, most likely prevented by high intracellular
diadenosine polyphosphate levels when glucose in present.
Instead, AMPK, in concert with altered levels/activity of
PCr+ADP
ATP+Cr
Glucose
APxA
expression
AMP+ATP
ADP+ADP
ADP
ADP
?
b
PCr+ADP
ATP+Cr
Glucose
APxA
AMP+ATP ADP+ADP
ADP
ADP
?
a
expression
Fig. 5 Hypothetical model of CRI-G1 KATP glucose-sensing illustrat-
ing a phosphotransfer mechanism controlled by AMPK activity. In
order to increase KATP activity in response to lowered extracellular
glucose concentration, the cell must have a mechanism that allows
transfer of information pertaining to altered energy levels from the
mitochondrion to the plasma membrane. This is denoted by AMPK-
dependent control of UCP2, creatine kinase (CK) and adenylate kinase
(AK) levels/activity. a Under high glucose (10 mM) conditions,
AMPK activity is low resulting in depleted UCP2, high levels of APxA
to maintain AK quiescent and high CK activity replenishing ATP.
Overall this results in a maintained high ATP:ADP ratio at the plasma
membrane, which in turn keeps AMPK inhibited and KATP predomi-
nantly closed. b If the cell is now exposed to lowered extracellular
glucose, the reduced metabolic flux results in increased AMPK activity
and decreased APxA levels. The combination of these events (possibly
in conjunction with increased UCP2 activity) results in reduced CK
activity and release of AK inhibition, thus allowing transmission of the
lowered mitochondrial ATP:ADP signal to KATP at the plasma
membrane
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UCP2, drives the generation of mitochondrial ADP that, when
glucose levels drop, leads to reduced diadenosine
polyphosphate-mediated inhibition of AK, which is transmit-
ted to KATP, allowing regulation of membrane potential in a
glucose-dependent manner. At present we have been unable to
address whether AMPK directly alters AK or CK activity,
therefore further experiments are required to determine wheth-
er AMPK directly or indirectly alters the phosphorylation
status of AK and/or CK in β-cells.
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